AbbVie Reports Promising Clinical Updates, Dividend Outlook
AbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,624 articlesAbbVie’s latest clinical progress could shape its dividend future. This guide breaks down what promising results mean...
As quantum progress accelerates, investors look for tech stocks before Q-Day that blend growth with resilience. Here ...
IT consulting faces mixed fortunes as budgets tighten and automation accelerates. This guide shows investors how to e...
Hexcel and Rocket Lab USA sit on opposite ends of the aerospace spectrum. One anchors aircraft efficiency; the other ...
If you’re wondering what the next year holds for stocks, this guide stays grounded. It blends data, real-world exampl...
IBM faces a tougher 2026 as AI and cloud shifts hit margins. With a sharp price drop and a sizable upside versus cons...
Two AI-driven stocks are at the forefront of the tech shift. This guide explains how they shape future technology, wh...
Rocket Lab climbs on Neutron milestones as investors weigh SpaceX IPO chatter. The move underscores growing appetite ...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A new wave of demand for Palantir’s AI-powered data platforms could reshape its five-year trajectory. This guide brea...
Arm is catching renewed investor attention as data-center demand for energy-efficient CPUs grows. Analysts say arm’s ...
Analysts see a path for Intel to reach higher stock levels by 2028 if its foundry expansion and AI data-center moment...